Confronti finanziari Dr. Lal PathLabs Limited

Azioni

Mercato chiuso - NSE India S.E. Altri mercati azionari 12:49:45 05/12/2025			Variaz. 5gg	Var. 1 gen.
3.029,60 ^INR	-0,80%		-0,73%	+0,97%

26/11	Dr. Lal PathLabs inaugura un laboratorio di test sui complementi in India	MT
26/11	Dr. Lal PathLabs lancia il primo laboratorio dedicato ai test del complemento in India	CI

Settore:

Regione:

Asse X:

Principali concorrenti

Aggiungi a un elenco 0 selezionato Solo clienti o iscritti possono usare questa funzione Accedi Registrati	Fatturato (Y-1)	Margine netto (Y-1)	Margine EBIT (Y-1)	ROE (Y-1)	ROA (Y-1)	Leverage (Y-1)
DR. LAL PATHLABS LIMITED	288 Mln	19,79%	22,49%	24,22%	18,83%	-1.45x
NATERA, INC.	1,7 Mrd	-11,22%	-13,1%	-19,42%	-13,87%	4.64x
SONIC HEALTHCARE LIMITED	6,32 Mrd	5,32%	9,43%	6,32%	3,33%	1.63x
RADNET, INC.	1,83 Mrd	0,15%	5,72%	0,29%	0,09%	0.99x
GENEDX HOLDINGS CORP.	305 Mln	-17,12%	3,15%	-	-	-3.46x
GUANGZHOU KINGMED DIAGNOSTICS GROUP CO., LTD.	985 Mln	-5,3%	-3,8%	-4,9%	-3,44%	-1.84x
FLEURY S.A.	1,24 Mrd	8,02%	15,59%	11,88%	5%	1.54x
NEOGENOMICS, INC.	661 Mln	-11,92%	-13,94%	1,55%	-	6.02x
DIAN DIAGNOSTICS GROUP CO.,LTD.	1,67 Mrd	-2,93%	-0,26%	-5%	1,64%	1x
VIJAYA DIAGNOSTIC CENTRE LIMITED	79,74 Mln	21%	29,74%	19,7%	-	-0.85x
H.U. GROUP HOLDINGS, INC.	1,62 Mrd	1,14%	1,09%	2%	1,66%	1.56x
METROPOLIS HEALTHCARE LIMITED	156 Mln	10,89%	14,6%	11,95%	-	-0.11x
OPKO HEALTH, INC.	713 Mln	-7,46%	-21,33%	-	-	-
BML, INC.	956 Mln	4,37%	6,54%	4,9%	5,72%	-
FULGENT GENETICS, INC.	283 Mln	-15,07%	-26,08%	1,32%	-	90.87x
NOVOGENE CO., LTD.	289 Mln	9,21%	10,97%	7,93%	5,44%	-
THYROCARE TECHNOLOGIES LIMITED	80,44 Mln	-	-	-	-	-
JIANGXI RIMAG GROUP CO., LTD.	104 Mln	-6,04%	-3,56%	-3,34%	-	-
INTEGRAL DIAGNOSTICS LIMITED	411 Mln	0,77%	11,16%	6,35%	2,91%	2.29x
Media	1,04 Mrd	0,2%	2,69%	4,11%	2,48%	7,34x
Media ponderata per Capi.	1,86 Mrd	-5,13%	-3,43%	-7,57%	-6,39%	3,71x